| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |